| 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort. |
32130059 |
J Clin Oncol |
| [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study. |
18550118 |
J Urol |
| A <i>K</i>-fold Averaging Cross-validation Procedure. |
27630515 |
J Nonparametr Stat |
| A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers. |
28482112 |
Biometrics |
| A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. |
12925511 |
Biostatistics |
| A Flexible Method for Diagnostic Accuracy with Biomarker Measurement Error. |
37251695 |
Mathematics (Basel) |
| A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies. |
31376183 |
Prostate |
| A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. |
27992432 |
PLoS One |
| A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. |
23232570 |
Adv Anat Pathol |
| A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. |
19435894 |
Cancer Res |
| A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. |
18056174 |
Clin Cancer Res |
| A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. |
18316555 |
Clin Cancer Res |
| A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers. |
35199349 |
Stat Med |
| A new family-based association test via a least-squares method. |
16451567 |
BMC Genet |
| A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies. |
19459841 |
Biometrics |
| A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. |
28376184 |
J Natl Cancer Inst |
| A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. |
30137376 |
J Natl Cancer Inst |
| A practical multifaceted approach to selecting differentially expressed genes. |
19455259 |
Cancer Inform |
| A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. |
20447916 |
Cancer Epidemiol Biomarkers Prev |
| A regularized multivariate regression approach for eQTL analysis. |
26085849 |
Stat Biosci |
| A sparse Ising model with covariates. |
25099186 |
Biometrics |
| A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data. |
27276420 |
Biometrics |
| A two-stage approach for dynamic prediction of time-to-event distributions. |
26748812 |
Stat Med |
| A web-based system for managing and co-ordinating multiple multisite studies. |
16279578 |
Clin Trials |
| Accommodating Covariates in ROC Analysis. |
20046933 |
Stata J |
| Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. |
19322904 |
Int J Cancer |
| Adding Rigor to Biomarker Evaluations-EDRN Experience. |
33172885 |
Cancer Epidemiol Biomarkers Prev |
| Addressing patient heterogeneity in disease predictive model development. |
34184256 |
Biometrics |
| Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve. |
22822245 |
Biometrika |
| Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. |
18477651 |
Am J Epidemiol |
| Adopting nested case-control quota sampling designs for the evaluation of risk markers. |
23807695 |
Lifetime Data Anal |
| Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. |
19362088 |
Gastroenterology |
| An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers. |
14615632 |
J Biomed Biotechnol |
| Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. |
24807840 |
J Proteome Res |
| Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. |
17981926 |
Clin Chem |
| Analyzing LC-MS/MS data by spectral count and ion abundance: two case studies. |
24163717 |
Stat Interface |
| Application of a methylation gene panel by quantitative PCR for lung cancers. |
16644104 |
Cancer Lett |
| Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways. |
19830254 |
J Am Stat Assoc |
| Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. |
16542256 |
Biometrics |
| Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. |
16443924 |
Biostatistics |
| Assessing accuracy of mammography in the presence of verification bias and intrareader correlation. |
15737102 |
Biometrics |
| Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. |
16622122 |
J Natl Cancer Inst |
| Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods. |
20527013 |
Stat Med |
| Assessing the diagnostic accuracy of a sequence of tests. |
12925502 |
Biostatistics |
| Assessing the incremental value of new biomarkers based on OR rules. |
30590454 |
Biostatistics |
| Assessing the value of risk predictions by using risk stratification tables. |
19017593 |
Ann Intern Med |
| Assessing treatment-selection markers using a potential outcomes framework. |
22299708 |
Biometrics |
| Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. |
30003238 |
JAMA Oncol |
| Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. |
28520829 |
JAMA Oncol |
| Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. |
14504198 |
Cancer Epidemiol Biomarkers Prev |
| Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers. |
19255861 |
Cancer Causes Control |
| Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis. |
37255388 |
|
| Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control Sampling. |
24039313 |
Ann Stat |
| Bayesian inference of hub nodes across multiple networks. |
30051914 |
Biometrics |
| Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. |
18310059 |
Biostatistics |
| Biases introduced by choosing controls to match risk factors of cases in biomarker research. |
22730452 |
Clin Chem |
| Biomarker evaluation and comparison using the controls as a reference population. |
18755739 |
Biostatistics |
| Biomarker evaluation under imperfect nested case-control design. |
33915597 |
Stat Med |
| Biomarker-based methods for determining noncompliance in a prevention trial. |
12505245 |
Control Clin Trials |
| Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. |
32532830 |
Cancer Epidemiol Biomarkers Prev |
| Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. |
34995129 |
J Clin Oncol |
| Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. |
12324514 |
Clin Chem |
| Boosting with missing predictors. |
19948743 |
Biostatistics |
| BOOTSTRAP INFERENCE FOR NETWORK CONSTRUCTION WITH AN APPLICATION TO A BREAST CANCER MICROARRAY STUDY. |
24563684 |
Ann Appl Stat |
| Borrowing Information across Populations in Estimating Positive and Negative Predictive Values. |
22021938 |
J R Stat Soc Ser C Appl Stat |
| Calibrate Variations in Biomarker Measures for Improving Prediction with Time-to-event Outcomes. |
33833826 |
Stat Biosci |
| Can urinary PCA3 supplement PSA in the early detection of prostate cancer? |
25385735 |
J Clin Oncol |
| Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. |
19758683 |
Urology |
| Cancer Biomarkers and Big Data: A Planetary Science Approach. |
32976775 |
Cancer Cell |
| Characterizing expected benefits of biomarkers in treatment selection. |
25190512 |
Biostatistics |
| Classification versus association models: should the same methods apply? |
20515278 |
Scand J Clin Lab Invest Suppl |
| Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. |
15741570 |
J Natl Cancer Inst |
| Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. |
38261000 |
|
| Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. |
19058137 |
Prostate |
| Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve. |
27058981 |
Stat Med |
| Combining biomarkers to detect disease with application to prostate cancer. |
14557109 |
Biostatistics |
| Combining multiple biomarkers linearly to maximize the partial area under the ROC curve. |
29082535 |
Stat Med |
| Combining predictors for classification using the area under the receiver operating characteristic curve. |
16542249 |
Biometrics |
| Combining results of microarray experiments: a rank aggregation approach. |
17049026 |
Stat Appl Genet Mol Biol |
| Combining several screening tests: optimality of the risk score. |
12230001 |
Biometrics |
| Commentary: Reporting standards are needed for evaluations of risk reclassification. |
21571811 |
Int J Epidemiol |
| Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). |
17671958 |
Stat Med |
| Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. |
16895044 |
Clin Trials |
| Comparison of two correlated ROC curves at a given specificity or sensitivity level. |
27324068 |
Stat Med |
| Comparison of two correlated ROC surfaces at a given pair of true classification rates. |
30010205 |
Stat Med |
| Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening. |
36733187 |
Stat Med |
| Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility. |
22238117 |
Stat Med |
| Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility. |
19097251 |
Stat Med |
| Constructing dynamic treatment regimes with shared parameters for censored data. |
31951041 |
Stat Med |
| Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. |
25471344 |
Cancer Epidemiol Biomarkers Prev |
| Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS. |
30076904 |
J Urol |
| Contrasting two frameworks for ROC analysis of ordinal ratings. |
20147599 |
Med Decis Making |
| Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules. |
33137463 |
J Thorac Oncol |
| Contributions of Circulating microRNAs for Early Detection of Lung Cancer. |
36077759 |
Cancers (Basel) |
| Copy number alterations are associated with metastatic-lethal progression in prostate cancer. |
32071439 |
Prostate Cancer Prostatic Dis |
| Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity. |
35134969 |
J Natl Cancer Inst |
| Cruciferous vegetable supplementation in a controlled diet study alters the serum peptidome in a GSTM1-genotype dependent manner. |
21272319 |
Nutr J |
| Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. |
12762451 |
Biometrics |
| Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. |
26431551 |
PLoS One |
| Design and estimation for evaluating principal surrogate markers in vaccine trials. |
23409839 |
Biometrics |
| Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. |
30699099 |
Am J Gastroenterol |
| Detecting genomic aberrations using products in a multiscale analysis. |
19817738 |
Biometrics |
| Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. |
33093149 |
Clin Cancer Res |
| Developing and evaluating risk prediction models with panel current status data. |
32562264 |
Biometrics |
| Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. |
38635241 |
|
| Development of common data elements: the experience of and recommendations from the early detection research network. |
12706181 |
Int J Med Inform |
| Diagnostic markers for early detection of ovarian cancer. |
18258665 |
Clin Cancer Res |
| Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. |
15580314 |
Oncogene |
| Distribution-free ROC analysis using binary regression techniques. |
12933607 |
Biostatistics |
| DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. |
32226005 |
PLoS Genet |
| DNA methylation profiles in African American prostate cancer patients in relation to disease progression. |
26902887 |
Genomics |
| Does the net reclassification improvement help us evaluate models and markers? |
24592500 |
Ann Intern Med |
| Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma. |
34954100 |
Contemp Clin Trials |
| Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? |
27001493 |
Clin Chem |
| Efficient use of longitudinal CD4 counts and viral load measures in survival analysis. |
22415871 |
Stat Med |
| Epidemiologic methods developments: a look forward to the year 2032. |
17855116 |
Ann Epidemiol |
| Epidemiology informing clinical practice: from bills of mortality to population laboratories. |
16341118 |
Nat Clin Pract Oncol |
| Estimating improvement in prediction with matched case-control designs. |
23358916 |
Lifetime Data Anal |
| Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative. |
25018574 |
J Am Stat Assoc |
| Estimating the capacity for improvement in risk prediction with a marker. |
18714084 |
Biostatistics |
| Estimating the diagnostic likelihood ratio of a continuous marker. |
20639522 |
Biostatistics |
| Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates. |
23601953 |
Acad Radiol |
| Estimation and Comparison of Receiver Operating Characteristic Curves. |
20161343 |
Stata J |
| Estimation and inference of predictive discrimination for survival outcome risk prediction models. |
35061146 |
Lifetime Data Anal |
| Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making. |
32761203 |
J Natl Cancer Inst |
| Evaluating and comparing biomarkers with respect to the area under the receiver operating characteristics curve in two-phase case-control studies. |
26883772 |
Biostatistics |
| Evaluating classification performance of biomarkers in two-phase case-control studies. |
30209824 |
Stat Med |
| Evaluating incremental values from new predictors with net reclassification improvement in survival analysis. |
23254468 |
Lifetime Data Anal |
| Evaluating longitudinal markers under two-phase study designs. |
29912281 |
Biostatistics |
| Evaluating markers for selecting a patient's treatment. |
15606407 |
Biometrics |
| Evaluating prognostic accuracy of biomarkers in nested case-control studies. |
21856652 |
Biostatistics |
| Evaluating prognostic accuracy of biomarkers under competing risk. |
22150576 |
Biometrics |
| Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. |
29301497 |
BMC Med Res Methodol |
| Evaluating technologies for classification and prediction in medicine. |
16320261 |
Stat Med |
| Evaluating the predictive value of biomarkers with stratified case-cohort design. |
23173848 |
Biometrics |
| Evaluating the predictiveness of a continuous marker. |
17489968 |
Biometrics |
| Evaluating the ROC performance of markers for future events. |
18064569 |
Lifetime Data Anal |
| Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet. |
15841498 |
Proteomics |
| Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. |
15613711 |
Clin Chem |
| Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues. |
18276773 |
J Mol Diagn |
| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. |
30651550 |
Nat Commun |
| Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. |
12807723 |
Carcinogenesis |
| Factors influencing serum CA125II levels in healthy postmenopausal women. |
11352859 |
Cancer Epidemiol Biomarkers Prev |
| FDR-controlling testing procedures and sample size determination for microarrays. |
15977294 |
Stat Med |
| Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context. |
22875756 |
Am J Epidemiol |
| GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score. |
30464023 |
Cancer Epidemiol Biomarkers Prev |
| Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. |
18612128 |
J Natl Cancer Inst |
| Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China. |
19064562 |
Cancer Epidemiol Biomarkers Prev |
| Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. |
20800559 |
Mol Oncol |
| Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women. |
17624589 |
Breast Cancer Res Treat |
| Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A. |
25733690 |
Mol Cell Proteomics |
| Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9. |
26998508 |
Cell Mol Gastroenterol Hepatol |
| Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. |
20395854 |
Ann Surg |
| Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence. |
26537180 |
Stat Med |
| Hybrid design evaluating new biomarkers when there is an existing screening test. |
33540472 |
Stat Med |
| Identification of osteopontin as a novel marker for early hepatocellular carcinoma. |
21953299 |
Hepatology |
| Identification of the optimal treatment regimen in the presence of missing covariates. |
31774192 |
Stat Med |
| Identifying optimal biomarker combinations for treatment selection through randomized controlled trials. |
25948620 |
Clin Trials |
| Identifying optimal biomarker combinations for treatment selection via a robust kernel method. |
25124089 |
Biometrics |
| Identifying target populations for screening or not screening using logic regression. |
15568185 |
Stat Med |
| iDINGO-integrative differential network analysis in genomics with Shiny application. |
29194470 |
Bioinformatics |
| Immunohistochemical validation of expression microarray results. |
15858137 |
J Mol Diagn |
| Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. |
19305635 |
|
| Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. |
26260109 |
Clin Gastroenterol Hepatol |
| Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. |
28258053 |
Cancer Epidemiol Biomarkers Prev |
| Improving biomarker identification with better designs and reporting. |
21666069 |
Clin Chem |
| IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS. |
28943991 |
Ann Appl Stat |
| Improving risk classification of critical illness with biomarkers: a simulation study. |
23566734 |
J Crit Care |
| Improving the quality of biomarker discovery research: the right samples and enough of them. |
25837819 |
Cancer Epidemiol Biomarkers Prev |
| Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. |
15824739 |
Oncogene |
| Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. |
37429366 |
|
| Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. |
29422418 |
Eur Urol Focus |
| Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. |
22277732 |
Cancer Prev Res (Phila) |
| Insights into latent class analysis of diagnostic test performance. |
17085745 |
Biostatistics |
| Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of fibrocystic breast conditions among Chinese women. |
16331609 |
Int J Cancer |
| Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. |
21653254 |
Mol Cell Proteomics |
| Integrating the predictiveness of a marker with its performance as a classifier. |
17982157 |
Am J Epidemiol |
| Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance. |
21968770 |
Epidemiology |
| Learning-based biomarker-assisted rules for optimized clinical benefit under a risk constraint. |
31833561 |
Biometrics |
| Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction". |
17679623 |
Circulation |
| Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. |
15105181 |
Am J Epidemiol |
| LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS. |
24204441 |
Ann Appl Stat |
| Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. |
34547437 |
Clin Gastroenterol Hepatol |
| Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability. |
22412972 |
PLoS One |
| MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. |
26342024 |
Cancer Prev Res (Phila) |
| Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. |
17501939 |
Biometrics |
| Measures to summarize and compare the predictive capacity of markers. |
20224632 |
Int J Biostat |
| Measuring the performance of markers for guiding treatment decisions. |
21320940 |
Ann Intern Med |
| Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test. |
20054437 |
Stat Biopharm Res |
| Model checking for ROC regression analysis. |
17447940 |
Biometrics |
| Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. |
29775599 |
Gastroenterology |
| Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. |
18483343 |
Cancer Epidemiol Biomarkers Prev |
| MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. |
36585434 |
Prostate Cancer Prostatic Dis |
| Net risk reclassification p values: valid or misleading? |
24681599 |
J Natl Cancer Inst |
| New connections between old pathways: PDK1 signaling promotes cellular transformation through PLK1-dependent MYC stabilization. |
24124229 |
Cancer Discov |
| New weighting methods when cases are only a subset of events in a nested case-control study. |
35754309 |
Biom J |
| Nidogen-2: a new serum biomarker for ovarian cancer. |
19883638 |
Clin Biochem |
| Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs. |
30555194 |
J Am Stat Assoc |
| Observational studies, clinical trials, and the women's health initiative. |
17943443 |
Lifetime Data Anal |
| Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. |
18794547 |
J Clin Oncol |
| On longitudinal prediction with time-to-event outcome: Comparison of modeling options. |
27438160 |
Biometrics |
| Optimized normalization for antibody microarrays and application to serum-protein profiling. |
15793073 |
Mol Cell Proteomics |
| Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. |
26327354 |
J Urol |
| Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. |
21372036 |
Cancer Prev Res (Phila) |
| Partial AUC estimation and regression. |
14601762 |
Biometrics |
| Partially supervised learning using an EM-boosting algorithm. |
15032790 |
Biometrics |
| Partly conditional survival models for longitudinal data. |
16011684 |
Biometrics |
| Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome. |
18948370 |
Clin Chem |
| Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). |
30664734 |
Prostate Cancer Prostatic Dis |
| Personalized Evaluation of Biomarker Value: A Cost-Benefit Perspective. |
27446505 |
Stat Biosci |
| Personalized Integrated Network Modeling of the Cancer Proteome Atlas. |
30297783 |
Sci Rep |
| Personalized statistical learning algorithms to improve the early detection of cancer using longitudinal biomarkers. |
35213362 |
Cancer Biomark |
| Phases of biomarker development for early detection of cancer. |
11459866 |
J Natl Cancer Inst |
| Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. |
18840817 |
J Natl Cancer Inst |
| Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms. |
26549697 |
Sci Rep |
| Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. |
33893071 |
Cancer Prev Res (Phila) |
| Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. |
18483327 |
Cancer Epidemiol Biomarkers Prev |
| Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. |
16921513 |
Prostate |
| Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. |
17455987 |
PLoS Med |
| Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. |
12483774 |
Stat Med |
| Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. |
18766180 |
Br J Cancer |
| Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score. |
20875091 |
BJU Int |
| Presence of simian virus 40 DNA sequences in human lymphomas. |
11897287 |
Lancet |
| Prevalidation of salivary biomarkers for oral cancer detection. |
22301830 |
Cancer Epidemiol Biomarkers Prev |
| Pro-surfactant protein B as a biomarker for lung cancer prediction. |
24248694 |
J Clin Oncol |
| Problems with risk reclassification methods for evaluating prediction models. |
21555714 |
Am J Epidemiol |
| Prospective accuracy for longitudinal markers. |
17688486 |
Biometrics |
| Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. |
19836772 |
J Urol |
| Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. |
15122736 |
Stat Med |
| Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes. |
14744831 |
Biostatistics |
| Quantifying peptide signal in MALDI-TOF mass spectrometry data. |
16195224 |
Mol Cell Proteomics |
| Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network. |
30439517 |
Contemp Clin Trials |
| Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study". |
23524037 |
Am J Epidemiol |
| Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values. |
30099328 |
Cancer Epidemiol |
| Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. |
29433975 |
Eur Urol |
| Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues. |
16944874 |
Anal Chem |
| Resampling Procedures for Making Inference under Nested Case-control Studies. |
24436503 |
J Am Stat Assoc |
| Response. |
25432412 |
J Natl Cancer Inst |
| Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies. |
37941446 |
|
| Robust prediction of t-year survival with data from multiple studies. |
20670303 |
Biometrics |
| Robust risk prediction with biomarkers under two-phase stratified cohort design. |
27037494 |
Biometrics |
| Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. |
29433973 |
Eur Urol |
| Sample size calculations for comparative studies of medical tests for detecting presence of disease. |
11870820 |
Stat Med |
| Scale-based normalization of spectral data. |
17192066 |
Cancer Biomark |
| SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. |
18024530 |
Clin Chem |
| Selecting Biomarkers for building optimal treatment selection rules using Kernel Machines. |
32921837 |
J R Stat Soc Ser C Appl Stat |
| Selecting differentially expressed genes from microarray experiments. |
12762450 |
Biometrics |
| Semiparametric estimation of time-dependent ROC curves for longitudinal marker data. |
15475423 |
Biostatistics |
| Semiparametric isotonic regression analysis for risk assessment under nested case-control and case-cohort designs. |
31868119 |
Stat Methods Med Res |
| Semiparametric methods for evaluating risk prediction markers in case-control studies. |
22822247 |
Biometrika |
| Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies. |
21562626 |
J R Stat Soc Ser C Appl Stat |
| Semiparametric models of time-dependent predictive values of prognostic biomarkers. |
19397579 |
Biometrics |
| Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. |
28376157 |
J Natl Cancer Inst |
| Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer. |
26813970 |
Cancer Prev Res (Phila) |
| Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. |
12097261 |
Cancer Res |
| Signal detection in high-resolution mass spectrometry data. |
18173224 |
J Proteome Res |
| Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. |
12455028 |
Int J Cancer |
| Standardizing diagnostic markers to evaluate and compare their performance. |
16135934 |
Epidemiology |
| Statistical Aspects of the Use of Biomarkers in Nutritional Epidemiology Research. |
19841649 |
Stat Biosci |
| Statistical considerations in combining biomarkers for disease classification. |
15322313 |
Dis Markers |
| Statistical inference for net benefit measures in biomarker validation studies. |
31732971 |
Biometrics |
| Statistical issues in the evaluation of screening and early detection modalities. |
18452826 |
Urol Oncol |
| Statistical Methods for Tissue Array Images - Algorithmic Scoring and Co-training. |
22984376 |
Ann Appl Stat |
| Strategies for validating biomarkers using data from a reference set. |
31420985 |
Biostatistics |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. |
21424820 |
Eur J Epidemiol |
| Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. |
21414753 |
J Clin Epidemiol |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. |
21407270 |
Eur J Hum Genet |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. |
21434890 |
Eur J Clin Invest |
| Structured penalties for functional linear models-partially empirical eigenvectors for regression. |
22639702 |
Electron J Stat |
| Study Design Considerations for Cancer Biomarker Discoveries. |
30828695 |
J Appl Lab Med |
| Survival model predictive accuracy and ROC curves. |
15737082 |
Biometrics |
| Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. |
32852532 |
JAMA Oncol |
| Targeted Search for Individualized Clinical Decision Rules to Optimize Clinical Outcomes. |
37323466 |
Stat Biosci |
| Telomere length in the colon declines with age: a relation to colorectal cancer? |
16537718 |
Cancer Epidemiol Biomarkers Prev |
| Testing for improvement in prediction model performance. |
23296397 |
Stat Med |
| The analysis of placement values for evaluating discriminatory measures. |
15180681 |
Biometrics |
| The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. |
26712941 |
Cancer Prev Res (Phila) |
| The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers. |
23193062 |
Clin Chem |
| The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator. |
23313212 |
J Urol |
| The joint graphical lasso for inverse covariance estimation across multiple classes. |
24817823 |
J R Stat Soc Series B Stat Methodol |
| The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curves. |
33530129 |
Stat Med |
| The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker. |
16428259 |
Biostatistics |
| The potential of genes and other markers to inform about risk. |
20160267 |
Cancer Epidemiol Biomarkers Prev |
| The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting. |
22552047 |
Urol Oncol |
| The sensitivity and specificity of markers for event times. |
16079162 |
Biostatistics |
| The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. |
19367279 |
Br J Cancer |
| Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. |
18382671 |
PLoS One |
| Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. |
19655041 |
J Am Stat Assoc |
| Tree-based Ensemble Methods For Individualized Treatment Rules. |
31650095 |
Biostat Epidemiol |
| Two-stage biomarker panel study and estimation allowing early termination for futility. |
25964662 |
Biostatistics |
| Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. |
18519043 |
Gastroenterology |
| Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. |
21363920 |
Cancer Res |
| Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients. |
32722209 |
Cancers (Basel) |
| Ultrasensitive detection and characterization of posttranslational modifications using surface-enhanced Raman spectroscopy. |
16737206 |
Anal Chem |
| Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design. |
26845527 |
Biometrics |
| Updating risk prediction tools: a case study in prostate cancer. |
22095849 |
Biom J |
| Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. |
23515404 |
Clin Cancer Res |
| Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. |
33080150 |
J Urol |
| Using the ROC curve for gauging treatment effect in clinical trials. |
16220481 |
Stat Med |
| Validation of a novel model for the early detection of hepatocellular carcinoma. |
30675135 |
Clin Proteomics |
| Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. |
30557738 |
Clin Gastroenterol Hepatol |
| Vitamin D receptor gene polymorphisms and prostate cancer risk. |
15065089 |
Prostate |
| When does combining markers improve classification performance and what are implications for practice? |
23348801 |
Stat Med |
